溶解性 | DMSO <20mg/mL; Ethanol <20mg/mL; DMF <20mg/mL |
存贮条件 | 储存温度-20°C |
产品介绍 | Salirasib是一种有效的竞争性prenylated protein methyltransferase (PPMTase)抑制剂, Ki为2.6 μM,其抑制Ras甲基化。Phase 2。 |
生化机理 |
Salirasib is a salicylic acid derivative with potential antineoplastic activity. Salirasib dislodges all Ras isoforms from their membrane-anchoring sites, thereby preventing activation of RAS signaling cascades that mediated cell proliferation, differentiation, and senescence. RAS signaling is believed to be abnormally activated in one-third of human cancers, including cancers of the pancreas, colon, lung and breast. Salirasib binds to a cell membrane anchor protein thereby selectively blocking a cascade of biochemical signals known as the Ras signaling pathway. The Ras pathway plays an important role in tumor growth and is believed to be abnormally activated in one-third of human cancers, including cancers of the pancreas, colon, lung and breast. Up to 90% of human pancreatic cancers are driven by aberrant oncogenic Ras signaling. |
别名 | ;S-Farnesylthiosalicylic acid; Farnesyl Thiosalicylic Acid; FTS |